Speech in Lords Chamber - Tue 14 Dec 2021
Breast Screening
"My Lords, while we wait for the routine screening programme to get back to normal, is there a fast-track mechanism for women who believe they have themselves detected a lump or a worrying change in their breast tissue to be screened and seen by a specialist?..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Breast Screening
Speech in Grand Committee - Wed 20 Oct 2021
Ageing: Science, Technology and Healthy Living (Science and Technology Committee Report)
"My Lords, I also thank the noble Lord, Lord Patel. I joined the Science and Technology Select Committee just in time for the inquiry that led to this report, so was able to appreciate the consummate ease with which he chaired the complex scoping exercise and then of course the …..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Ageing: Science, Technology and Healthy Living (Science and Technology Committee Report)
Written Question
Wednesday 14th April 2021
Asked by:
Baroness Sheehan (Liberal Democrat - Life peer)
Question
to the Department of Health and Social Care:
To ask Her Majesty's Government when they plan to publish daily data on the number of people vaccinated by (1) the Pfizer/BioNTech, and (2) the Oxford/Astrazeneca, vaccine.
Answered by Lord Bethell
The Government has no plans to publish daily data on the number of people vaccinated by the Pfizer/BioNTech and Oxford/AstraZeneca vaccine. Daily data on the number of people vaccinated is published in an online only format.
Speech in Lords Chamber - Mon 22 Mar 2021
Health and Social Care Update
"My Lords, the Serum Institute of India is producing a billion doses of the Oxford/AstraZeneca vaccine this year. However, we hear that the rate of production may be compromised because of delays in the supply chain of essential items from the US. What dialogue have our Government had with their …..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Health and Social Care Update
Written Question
Tuesday 16th March 2021
Asked by:
Baroness Sheehan (Liberal Democrat - Life peer)
Question
to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of the factors which they consider will most limit the roll out of the Oxford/Astrazeneca vaccine at scale; and what such factors they have identified.
Answered by Lord Bethell
We have invested over £300 million towards manufacturing and deploying successful vaccines in the United Kingdom, including ensuring we have adequate provision, transportation, personal protective equipment, and logistical expertise to do so.
All vaccines will present different logistical requirements, but the National Health Service has planned for all eventualities, including securing additional fridges to support the deployment of the Oxford/AstraZeneca vaccine.
Speech in Lords Chamber - Thu 04 Mar 2021
Covid-19 Update
"My Lords, vaccines are key to getting us to a position where we can live with the virus, but we really must listen to scientists telling us that we must control the virus everywhere. While our support for the COVAX initiative is to be applauded, it cannot work effectively without …..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Covid-19 Update
Speech in Lords Chamber - Thu 11 Feb 2021
Covid-19
"My Lords, hotel quarantine measures, albeit late and incomplete, are nevertheless welcome—better late than never. However, as things stand, mankind cannot outpace the mutating virus without a global vaccine plan in place. When do the Government think that the time will be right to call for a leader’s summit to …..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Covid-19
Written Question
Tuesday 2nd February 2021
Asked by:
Baroness Sheehan (Liberal Democrat - Life peer)
Question
to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of (1) the implications of the emergence of variants of COVID-19, and (2) the potential for future mutations of that virus; and what plans they have made for the rapid acquisition of any re-purposed vaccine that may be needed.
Answered by Lord Bethell
There is currently no evidence that the vaccines do not work against the new strains but our experts are examining this closely. The Medicines and Healthcare products Regulatory Agency (MHRA) is in discussion with vaccine manufacturers on potential modifications to current vaccines that may improve their effectiveness against new virus variants, if required. The MHRA will continue to process any application rapidly and rigorously, seeking advice from its independent expert committee, the Commission on Human Medicines and authorise any new variant vaccine as soon as data on safety, quality and efficacy are satisfactory.
Speech in Lords Chamber - Wed 20 Jan 2021
Covid-19: Vaccination
"My Lords, can the Minister say how concerned the Government are that diminishing efficacy in partially immunised people among a population with high prevalence of the disease, as we have in the UK, will foster ideal conditions for the virus to mutate into vaccine-resistant forms?..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Covid-19: Vaccination
Speech in Lords Chamber - Mon 18 Jan 2021
Mental Health Act Reform
"My Lords, sadly, I have personal experience of having to invoke the Mental Health Act. It is a dreadful process. It concerns me that one of the reforms proposed is to tighten the criteria for civil patients’ detention by raising the threshold for risk of harm. Does the Minister agree …..."Baroness Sheehan - View Speech
View all Baroness Sheehan (LD - Life peer) contributions to the debate on: Mental Health Act Reform